Congenital Adrenal Hyperplasia due to 3-Beta-Hydroxysteroid Dehydrogenase Type 2 (HSD3B2) Gene Analysis
Congenital Adrenal Hyperplasia (CAH) due to HSD3B2 deficiency is a rare inherited disorder caused by mutations in the HSD3B2 gene. This condition affects the production of essential steroid hormones, including cortisol, aldosterone, and sex hormones, leading to adrenal insufficiency and abnormalities in sexual development.
Test Overview
The HSD3B2 Gene Analysis is a molecular genetic test that identifies disease-causing variants in the HSD3B2 gene to confirm the diagnosis of 3-beta-hydroxysteroid dehydrogenase type 2 deficiency.
When is this Test Recommended?
Suspected Congenital Adrenal Hyperplasia (CAH)
Salt-wasting crisis in newborns or infants
Ambiguous genitalia at birth
Delayed or abnormal puberty
Adrenal insufficiency symptoms
Family history of HSD3B2 deficiency or CAH
Carrier screening for at-risk couples
Prenatal or family genetic evaluation
Symptoms May Include
Poor feeding and vomiting in newborns
Dehydration and electrolyte imbalance
Failure to thrive
Low blood pressure
Ambiguous genitalia
Early virilization or delayed puberty
Hormonal imbalance
Sample Required
Peripheral Blood (EDTA)
Test Method
DNA Sequencing (NGS/Sanger Sequencing with variant confirmation as required)
Benefits
Confirms the genetic cause of CAH
Enables accurate diagnosis and classification
Supports early treatment and hormone replacement therapy
Assists in genetic counseling and family planning
Identifies carriers within affected families
Helps guide prenatal risk assessment
Who Should Get Tested?
Newborns with suspected adrenal disorders
Children with unexplained adrenal insufficiency
Individuals with ambiguous genitalia
Patients with abnormal steroid hormone profiles
Family members of affected individuals
Couples planning pregnancy with a family history of CAH
Preparation
No special preparation is required. Genetic counseling is recommended before and after testing for appropriate interpretation of results.